Horisaki, K.; Yoshikawa, S.; Omata, W.; Tsutsumida, A.; Kiyohara, Y.
The Real-World Efficacy and Side Effects of Different Nivolumab Regimens in Japanese Patients with Advanced Melanoma: A Single-Center Retrospective Study. Cancers 2025, 17, 2299.
https://doi.org/10.3390/cancers17142299
AMA Style
Horisaki K, Yoshikawa S, Omata W, Tsutsumida A, Kiyohara Y.
The Real-World Efficacy and Side Effects of Different Nivolumab Regimens in Japanese Patients with Advanced Melanoma: A Single-Center Retrospective Study. Cancers. 2025; 17(14):2299.
https://doi.org/10.3390/cancers17142299
Chicago/Turabian Style
Horisaki, Ken, Shusuke Yoshikawa, Wataru Omata, Arata Tsutsumida, and Yoshio Kiyohara.
2025. "The Real-World Efficacy and Side Effects of Different Nivolumab Regimens in Japanese Patients with Advanced Melanoma: A Single-Center Retrospective Study" Cancers 17, no. 14: 2299.
https://doi.org/10.3390/cancers17142299
APA Style
Horisaki, K., Yoshikawa, S., Omata, W., Tsutsumida, A., & Kiyohara, Y.
(2025). The Real-World Efficacy and Side Effects of Different Nivolumab Regimens in Japanese Patients with Advanced Melanoma: A Single-Center Retrospective Study. Cancers, 17(14), 2299.
https://doi.org/10.3390/cancers17142299